Johnson & Johnson (NYSE: JNJ) is 8.05% higher on its value in year-to-date trading and has touched a low of $140.68 and a high of $169.99 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The JNJ stock was last observed hovering at around $164.36 in the last trading session, with the day’s gains setting it 3.57%.
Currently trading at $167.93, the stock is 6.73% and 8.45% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.28 million and changing 2.17% at the moment leaves the stock 8.14% off its SMA200. JNJ registered 16.12% gain for a year compared to 6-month gain of 14.21%. The firm has a 50-day simple moving average (SMA 50) of $154.8424 and a 200-day simple moving average (SMA200) of $155.29445.
The stock witnessed a 12.11% loss in the last 1 month and extending the period to 3 months gives it a 7.02%, and is 8.22% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.97% over the week and 1.53% over the month.
Johnson & Johnson (JNJ) has around 139800 employees, a market worth around $404.05B and $90.63B in sales. Current P/E ratio is 17.96 and Fwd P/E is 14.80. Profit margin for the company is 25.00%. Distance from 52-week low is 19.37% and -1.21% from its 52-week high. The company has generated returns on investments over the last 12 months (19.46%).
with sales reaching $23.74B over the same period.The EPS is expected to grow by 8.52% this year, but quarterly earnings will post 5.19% year-over-year. Quarterly sales are estimated to grow 5.63% in year-over-year returns.
Johnson & Johnson (JNJ) Top Institutional Holders
5069.0 institutions hold shares in Johnson & Johnson (JNJ), with institutional investors hold 74.13% of the company’s shares. The shares outstanding are 2.41B, and float is at 2.40B with Short Float at 0.66%. Institutions hold 74.09% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 229.04 million shares valued at $33.48 billion. The investor’s holdings represent 9.5164% of the JNJ Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 198.19 million shares valued at $28.97 billion to account for 8.2345 of the shares outstanding. The other top investors are STATE STREET CORP which holds 133.09 million shares representing 5.5298% and valued at over $19.45 billion, while GEODE CAPITAL MANAGEMENT, LLC holds 2.2894 of the shares totaling 55.1 million with a market value of $8.03 billion.
Johnson & Johnson (JNJ) Insider Activity
The most recent transaction is an insider sale by REED JOHN C, the company’s EVP, Innovative Medicine, R&D. SEC filings show that REED JOHN C sold 19,137 shares of the company’s common stock on Jul 17 ’25 at a price of $163.55 per share for a total of $3.13 million. Following the sale, the insider now owns 10658.0 shares.
Still, SEC filings show that on Feb 25 ’25, Decker Robert J (VP Corporate Controller) disposed off 6,999 shares at an average price of $165.88 for $1.16 million. The insider now directly holds 21,001 shares of Johnson & Johnson (JNJ).
